clinical trials in Mexico

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Artificial intelligence in clinical trials in Mexico

Artificial intelligence in clinical trials in Mexico – Top CRO in Latin America

Artificial Intelligence (AI) has emerged as a powerful tool in various industries, and its impact on healthcare, particularly in clinical trials, is undeniable. Mexico, a country with a growing healthcare sector, is embracing AI to enhance the efficiency, accuracy, and safety of clinical trials.

In this blog, we will explore how AI is revolutionizing the landscape of clinical trials in Mexico, offering tremendous potential for improving patient outcomes, accelerating drug development, and advancing medical research.

Enhancing Patient Recruitment and Selection

One of the significant challenges in clinical trials is patient recruitment and selection. AI-based algorithms and machine learning techniques can analyze vast amounts of patient data, electronic health records (EHRs), and genomic information to identify potential candidates more efficiently. By automating the screening process,

AI reduces the burden on researchers and enables faster identification of suitable participants. This not only speeds up trial enrollment but also ensures a diverse and representative patient population, enhancing the generalizability of study results.

Optimizing Trial Design and Protocol

AI plays a vital role in optimizing trial design and protocol development. By analyzing historical clinical trial data, AI algorithms can identify patterns and insights that help researchers refine study designs, select appropriate endpoints, and determine optimal sample sizes.

Additionally, AI enables adaptive trial designs, where the protocol can be modified in real-time based on ongoing data analysis. This flexibility leads to more efficient trials, as adjustments can be made to address unforeseen challenges or take advantage of emerging trends.

Improving Data Collection and Analysis

Accurate and comprehensive data collection and analysis are crucial in clinical trials. AI-powered technologies, such as natural language processing (NLP) and image recognition, enable automated data extraction from various sources, including medical records, laboratory reports, and imaging scans. This not only eliminates the need for manual data entry but also reduces the likelihood of errors and enhances data accuracy.

AI algorithms can analyze the collected data rapidly, identifying trends, correlations, and adverse events that might otherwise go unnoticed.

Artificial intelligence in clinical trials in Mexico

Artificial intelligence in clinical trials in Mexico

Artificial intelligence in clinical trials in Mexico

Enhancing Safety Monitoring and Pharmacovigilance

Patient safety is paramount in clinical trials. AI algorithms can continuously monitor patient data and detect potential adverse events or safety concerns in real-time. By analyzing a vast amount of data, including vital signs, laboratory values, and patient-reported outcomes,

AI can flag unusual patterns or deviations, prompting immediate intervention. Additionally, AI can assist in pharmacovigilance by monitoring post-market drug safety, identifying potential risks, and contributing to early detection and prevention of adverse reactions.

Accelerating Drug Discovery and Development

AI has the potential to revolutionize the drug discovery and development process. In Mexico, AI is being used to analyze vast repositories of scientific literature, clinical trial data, and molecular information to identify potential drug targets, predict drug efficacy, and optimize drug formulations.

AI-powered virtual screening methods can quickly screen and prioritize thousands of compounds for further investigation, reducing the time and cost associated with traditional experimental methods. This acceleration of the drug development process ultimately benefits patients by bringing new treatments to market faster.


Artificial Intelligence is transforming the landscape of clinical trials in Mexico, empowering researchers and healthcare professionals to overcome various challenges and improve patient outcomes. By streamlining patient recruitment, optimizing trial design, enhancing data collection and analysis, ensuring safety monitoring, and accelerating drug discovery,

AI offers tremendous potential to revolutionize healthcare in Mexico. Embracing AI-driven technologies will not only enhance the efficiency and effectiveness of clinical trials but also pave the way for personalized medicine and more targeted treatment approaches.

As AI continues to evolve, its integration into clinical practice in Mexico will undoubtedly drive innovation and propel the country’s healthcare system forward.

Artificial intelligence in clinical trials in Mexico

Source: Roche

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

clinical trials in Mexico

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
clinical trials in Mexico

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

clinical trials in Mexico

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

clinical trials in Mexico

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

clinical trials in Mexico

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

clinical trials in Mexico

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
clinical trials in Mexico

The Cohortias Team

clinical trials in Mexico

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

clinical trials in Mexico

Network & Partnerships